Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)

A. Menter; R. B. Warren; R. G. Langley; J. F. Merola; L. N. Kerr; E. B. Dennehy; D. Shrom; D. Amato; Y. Okubo; K. Reich

doi:10.1111/jdv.14237

Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)

A. Menter, R. B. Warren, R. G. Langley, J. F. Merola, L. N. Kerr, E. B. Dennehy, D. Shrom, D. Amato, Y. Okubo, K. Reich

Inernational Relations Division

Research output: Contribution to journal › Article › peer-review

66 Citations (Scopus)

Original language	English
Pages (from-to)	1686-1692
Number of pages	7
Journal	Journal of the European Academy of Dermatology and Venereology
Volume	31
Issue number	10
DOIs	https://doi.org/10.1111/jdv.14237
Publication status	Published - Oct 2017

ASJC Scopus Subject Areas

Dermatology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jdv.14237

Fingerprint

Dive into the research topics of 'Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)'. Together they form a unique fingerprint.

Cite this

Menter, A., Warren, R. B., Langley, R. G., Merola, J. F., Kerr, L. N., Dennehy, E. B., Shrom, D., Amato, D., Okubo, Y., & Reich, K. (2017). Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3). Journal of the European Academy of Dermatology and Venereology, 31(10), 1686-1692. https://doi.org/10.1111/jdv.14237

Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3). / Menter, A.; Warren, R. B.; Langley, R. G. et al.
In: Journal of the European Academy of Dermatology and Venereology, Vol. 31, No. 10, 10.2017, p. 1686-1692.

Research output: Contribution to journal › Article › peer-review

Menter, A, Warren, RB, Langley, RG, Merola, JF, Kerr, LN, Dennehy, EB, Shrom, D, Amato, D, Okubo, Y & Reich, K 2017, 'Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)', Journal of the European Academy of Dermatology and Venereology, vol. 31, no. 10, pp. 1686-1692. https://doi.org/10.1111/jdv.14237

Menter A, Warren RB, Langley RG, Merola JF, Kerr LN, Dennehy EB et al. Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3). Journal of the European Academy of Dermatology and Venereology. 2017 Oct;31(10):1686-1692. doi: 10.1111/jdv.14237

Menter, A. ; Warren, R. B. ; Langley, R. G. et al. / Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement : results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3). In: Journal of the European Academy of Dermatology and Venereology. 2017 ; Vol. 31, No. 10. pp. 1686-1692.

@article{3ab8b3d5282b4a268feccfb55c04cacd,

title = "Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)",

author = "A. Menter and Warren, {R. B.} and Langley, {R. G.} and Merola, {J. F.} and Kerr, {L. N.} and Dennehy, {E. B.} and D. Shrom and D. Amato and Y. Okubo and K. Reich",

note = "Publisher Copyright: {\textcopyright} 2017 European Academy of Dermatology and Venereology",

year = "2017",

month = oct,

doi = "10.1111/jdv.14237",

language = "English",

volume = "31",

pages = "1686--1692",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement

T2 - results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)

AU - Menter, A.

AU - Warren, R. B.

AU - Langley, R. G.

AU - Merola, J. F.

AU - Kerr, L. N.

AU - Dennehy, E. B.

AU - Shrom, D.

AU - Amato, D.

AU - Okubo, Y.

AU - Reich, K.

PY - 2017/10

Y1 - 2017/10

UR - http://www.scopus.com/inward/record.url?scp=85018336857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018336857&partnerID=8YFLogxK

U2 - 10.1111/jdv.14237

DO - 10.1111/jdv.14237

M3 - Article

C2 - 28322474

AN - SCOPUS:85018336857

SN - 0926-9959

VL - 31

SP - 1686

EP - 1692

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

IS - 10

ER -

Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this